Phillip E. Lee - 08 Dec 2023 Form 4 Insider Report for Vaxart, Inc. (VXRT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Mar 2024, 20:10:15 UTC
Prior SEC filing
14 Jun 2023
Next SEC filing
13 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Edward Berg, Attorney-in-Fact

Key filing fact

Phillip E. Lee filed Form 4 for Vaxart, Inc. (VXRT) on 20 Mar 2024.

Key facts

  • This page summarizes Phillip E. Lee's Form 4 filing for Vaxart, Inc. (VXRT).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 20 Mar 2024, 20:10.

Change

  • Previous filing in this sequence was filed on 14 Jun 2023.
  • Current net transaction value: -$28,701.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VXRT transaction

Common Stock

Tax liability

Transaction value
$24,957
Shares
-35,151
Change %
-18%
Price
$0.7100
Shares after
157,751
Date
08 Dec 2023
Ownership
Direct
Footnotes
F1, F2
VXRT transaction

Common Stock

Tax liability

Transaction value
$3,744
Shares
-5,943
Change %
-3.8%
Price
$0.6300*
Shares after
151,808
Date
15 Dec 2023
Ownership
Direct
Footnotes
F1, F3
VXRT transaction

Common Stock

Award

Transaction value
$0
Shares
+90,000
Change %
+59%
Price
$0.000000
Shares after
241,808
Date
18 Mar 2024
Ownership
Direct
Footnotes
F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VXRT transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+410,000
Change %
Price
$0.000000
Shares after
410,000
Date
18 Mar 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
410,000
Exercise price
$1.16
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

This transaction is being reported late due to administrative oversight.

Footnote F2

Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of December 8, 2023.

Footnote F3

Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of December 15, 2023.

Footnote F4

Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 18, 2024, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date.

Footnote F5

The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 18, 2025, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 18, 2028.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .